Duygu Sari

1.8k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Duygu Sari is a scholar working on Molecular Biology, Immunology and Biotechnology. According to data from OpenAlex, Duygu Sari has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Biotechnology. Recurrent topics in Duygu Sari's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Transgenic Plants and Applications (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Duygu Sari is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Transgenic Plants and Applications (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Duygu Sari collaborates with scholars based in United States, Türkiye and France. Duygu Sari's co-authors include Nikolaos Patsoukis, Vassiliki A. Boussiotis, Victoria Petkova, Kankana Bardhan, Pranam Chatterjee, Gordon J. Freeman, Bianling Liu, Lequn Li, Edward D. Karoly and Lauren N. Bell and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Duygu Sari

19 papers receiving 1.4k citations

Hit Papers

PD-1 alters T-cell metabolic reprogramming by inhibiting ... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duygu Sari United States 10 854 641 459 256 114 22 1.4k
Nikita Kolhatkar United States 13 1.2k 1.4× 682 1.1× 433 0.9× 219 0.9× 130 1.1× 18 1.8k
Sung Hoon Cho United States 16 723 0.8× 415 0.6× 583 1.3× 296 1.2× 84 0.7× 30 1.4k
Hyun-Il Cho South Korea 15 700 0.8× 447 0.7× 389 0.8× 235 0.9× 118 1.0× 35 1.1k
Je-In Youn United States 8 1.3k 1.5× 622 1.0× 489 1.1× 309 1.2× 102 0.9× 9 1.7k
Osamu Shimozato Japan 23 927 1.1× 680 1.1× 500 1.1× 163 0.6× 92 0.8× 61 1.6k
Elise Alspach United States 14 856 1.0× 679 1.1× 632 1.4× 210 0.8× 112 1.0× 19 1.7k
Teresa Lozano Spain 20 717 0.8× 481 0.8× 393 0.9× 133 0.5× 65 0.6× 43 1.2k
Thornton W. Thompson United States 10 1.1k 1.3× 769 1.2× 333 0.7× 100 0.4× 136 1.2× 10 1.5k
Norma Bloy France 19 841 1.0× 776 1.2× 483 1.1× 117 0.5× 143 1.3× 39 1.5k
Jessica Dal Col Italy 20 550 0.6× 554 0.9× 469 1.0× 125 0.5× 131 1.1× 35 1.2k

Countries citing papers authored by Duygu Sari

Since Specialization
Citations

This map shows the geographic impact of Duygu Sari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duygu Sari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duygu Sari more than expected).

Fields of papers citing papers by Duygu Sari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duygu Sari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duygu Sari. The network helps show where Duygu Sari may publish in the future.

Co-authorship network of co-authors of Duygu Sari

This figure shows the co-authorship network connecting the top 25 collaborators of Duygu Sari. A scholar is included among the top collaborators of Duygu Sari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duygu Sari. Duygu Sari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sari, Duygu, et al.. (2025). Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment. Life. 15(8). 1312–1312. 1 indexed citations
3.
Sari, Duygu, et al.. (2024). Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics. Translational Oncology. 47. 102055–102055. 3 indexed citations
4.
Sari, Duygu, et al.. (2024). Ektacytometric examination of red blood cells’ morphodynamical features in diabetic nephropathy patients. SHILAP Revista de lepidopterología. 49(6). 727–738.
5.
Sari, Duygu, et al.. (2022). Advances in CRISPR-Cas9 for the Baculovirus Vector System: A Systematic Review. Viruses. 15(1). 54–54. 4 indexed citations
6.
Beker, Mustafa Çağlar, et al.. (2022). Dual action of exosomes derived from in vitro Aβ toxicity model: The role of age for pathological response. Archives of Gerontology and Geriatrics. 106. 104874–104874. 4 indexed citations
7.
Sari, Duygu, Joshua C. Bufton, Kapil Gupta, et al.. (2021). VLP‐factory™ and ADDomer©: Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display. Current Protocols. 1(3). e55–e55. 9 indexed citations
8.
Sari, Duygu, et al.. (2021). Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM). Biomedical Journal. 45(2). 289–298. 2 indexed citations
9.
Lim, Jackwee, et al.. (2021). Siglecs as Therapeutic Targets in Cancer. Biology. 10(11). 1178–1178. 38 indexed citations
10.
Sari, Duygu, Shervin Bahrami, Magdalena Janina Laska, et al.. (2019). High-Throughput Production of Influenza Virus-Like Particle (VLP) Array by Using VLP-factory™, a MultiBac Baculoviral Genome Customized for Enveloped VLP Expression. Methods in molecular biology. 2025. 213–226. 9 indexed citations
11.
Gupta, Kapil, et al.. (2019). MultiBac: Baculovirus-Mediated Multigene DNA Cargo Delivery in Insect and Mammalian Cells. Viruses. 11(3). 198–198. 31 indexed citations
12.
Patsoukis, Nikolaos, Kankana Bardhan, Jessica D. Weaver, et al.. (2017). The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression. Science Signaling. 10(493). 21 indexed citations
13.
Sari, Duygu, Kapil Gupta, Deepak B. Thimiri Govinda Raj, et al.. (2016). The MultiBac Baculovirus/Insect Cell Expression Vector System for Producing Complex Protein Biologics. Advances in experimental medicine and biology. 896. 199–215. 60 indexed citations
14.
Gupta, Kapil, Duygu Sari, Matthias Haffke, Simon Trowitzsch, & Imre Berger. (2016). Zooming in on Transcription Preinitiation. Journal of Molecular Biology. 428(12). 2581–2591. 26 indexed citations
15.
Patsoukis, Nikolaos, Kankana Bardhan, Pranam Chatterjee, et al.. (2015). PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nature Communications. 6(1). 6692–6692. 908 indexed citations breakdown →
16.
Bardhan, Kankana, Nikolaos Patsoukis, Duygu Sari, et al.. (2015). PD-1 Inhibits TCR Proximal Signaling By Sequestering SHP-2 Phosphatase and Facilitating Csk-Mediated Inhibitory Phosphorylation of Lck. Blood. 126(23). 283–283. 3 indexed citations
17.
Patsoukis, Nikolaos, Le‐Qun Li, Duygu Sari, Victoria Petkova, & Vassiliki A. Boussiotis. (2013). PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2. Molecular and Cellular Biology. 33(16). 3091–3098. 154 indexed citations
18.
Chatterjee, Pranam, Nikolaos Patsoukis, Duygu Sari, & Vassiliki A. Boussiotis. (2012). PD-1 Couples Glucose Starvation with Autophagy and Survival Through AMPK-Mediated Phosphorylation of Ulk1. Blood. 120(21). 836–836.
19.
Patsoukis, Nikolaos, Duygu Sari, & Vassiliki A. Boussiotis. (2012). PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A. Cell Cycle. 11(23). 4305–4309. 108 indexed citations
20.
Patsoukis, Nikolaos, Lequn Li, Duygu Sari, & Vassiliki A. Boussiotis. (2012). PD-1 Decreases PTEN Protein Stability While Increasing PTEN Phosphatase Activity by Inhibiting CK2.. Blood. 120(21). 2145–2145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026